Silence Therapeutics plc
SLN
$7.35
$0.456.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 85.11M | 102.19M | 114.16M | 136.53M | 147.33M |
| Total Receivables | 24.61M | 22.18M | 20.04M | 16.84M | 26.91M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.93M | -- | -- | -- | 13.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 9.26M | 14.36M | 16.42M | -- |
| Total Current Assets | 118.66M | 133.63M | 148.55M | 169.79M | 187.37M |
|
|
|||||
| Total Current Assets | 118.66M | 133.63M | 148.55M | 169.79M | 187.37M |
| Net Property, Plant & Equipment | 1.75M | 1.85M | 1.83M | 1.80M | 1.98M |
| Long-term Investments | 10.62M | 10.61M | 10.62M | 9.78M | 9.39M |
| Goodwill | 10.62M | 10.61M | 10.62M | 9.78M | 9.39M |
| Total Other Intangibles | 288.00K | 300.00K | 317.00K | 310.00K | 312.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 127.00K | 399.00K | 3.91M | 3.61M | 3.59M |
| Total Assets | 131.44M | 146.79M | 165.23M | 185.30M | 202.64M |
|
|
|||||
| Total Accounts Payable | 4.41M | 16.99M | 14.31M | 18.81M | 3.70M |
| Total Accrued Expenses | 8.91M | -- | -- | -- | 12.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 89.00K | 85.00K | -- | 60.00K | 117.00K |
| Total Finance Division Other Current Liabilities | 207.00K | 301.00K | 457.00K | 392.00K | 958.00K |
| Total Other Current Liabilities | 207.00K | 301.00K | 457.00K | 392.00K | 958.00K |
| Total Current Liabilities | 13.61M | 17.38M | 14.77M | 19.26M | 16.82M |
|
|
|||||
| Total Current Liabilities | 13.61M | 17.38M | 14.77M | 19.26M | 16.82M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 71.00K | 97.00K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 55.45M | 55.25M | 56.31M | 53.29M | 51.79M |
| Total Liabilities | 69.14M | 72.73M | 71.08M | 72.56M | 68.61M |
|
|
|||||
| Common Stock & APIC | 627.85M | 627.94M | 625.40M | 623.36M | 619.85M |
| Retained Earnings | -562.57M | -550.80M | -529.84M | -502.54M | -474.04M |
| Treasury Stock & Other | -2.98M | -3.07M | -1.40M | -8.08M | -11.78M |
| Total Common Equity | 62.30M | 74.06M | 94.16M | 112.74M | 134.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 62.30M | 74.06M | 94.16M | 112.74M | 134.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 62.30M | 74.06M | 94.16M | 112.74M | 134.02M |
|
|
|||||